VPS35 Gene (PARK17) Parkinson's Disease Genetic Test in UAE | 2800 AED | DHA Licensed

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Facility License: DHA 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

Test Overview & Methodology

The VPS35 Gene (PARK17) Parkinson's Disease Genetic Test uses Next Generation Sequencing to identify pathogenic mutations in the VPS35 gene, confirming autosomal dominant Parkinson’s disease with high diagnostic precision.

Feature	Our Test (NGS)	Closest Alternative (Sanger Sequencing)
Diagnostic Sensitivity	99.9% for all exon-level variants	~99.0% for targeted regions only
Methodology	Next Generation Sequencing (NGS) – full gene analysis	Single-gene Sanger sequencing of selected exons
Turnaround Time	3 to 4 Weeks	4 to 6 Weeks
Sample Types	Whole Blood, Extracted DNA, or One Drop Blood on FTA Card

Physician Insight & Safety Protocols

“As a consultant in medical genetics, I emphasize that genetic testing for Parkinson's disease should be accompanied by comprehensive pre- and post-test counseling. This test identifies VPS35 mutations that can clarify diagnosis and guide family planning, but results must be interpreted in the context of the patient's full clinical picture. A positive result does not determine disease severity, and a negative result does not rule out other genetic causes.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License: 9294403

Medication Advisory

Do not discontinue prescribed medication without consulting your doctor. Genetic test results inform long-term management, not immediate drug changes.

Safety Exclusion Criteria & Emergency Signs

Exclusion Criteria: Recent allogeneic hematopoietic stem cell transplant (may interfere with DNA analysis); inability to provide informed consent; severe psychiatric comorbidity requiring stabilization before genetic testing.
ER Red Flags (seek immediate care): Rapid worsening of parkinsonian symptoms, signs of neuroleptic malignant syndrome (high fever, stiffness, altered consciousness), suicidal ideation or psychosis following result disclosure.

Patient FAQ & Clinical Guidance

1. What is the VPS35 Gene (PARK17) Parkinson's Disease Genetic Test?

This test detects VPS35 gene mutations causing autosomal dominant Parkinson's disease for diagnosis and family risk assessment. It analyzes DNA using Next Generation Sequencing. The test is recommended for individuals with early-onset Parkinson's or a family history of the disease, guiding personalized treatment and family planning decisions.

2. How long does it take to get results?

Results are typically available within 3 to 4 weeks from sample receipt, utilizing advanced NGS technology. This turnaround time includes library preparation, sequencing, bioinformatics analysis, and clinical interpretation by molecular geneticists. Expedited reporting may be possible upon request for urgent clinical scenarios.

3. Does insurance cover the cost of this analysis?

Direct billing verification is available via WhatsApp; many UAE insurers cover genetic testing when medically necessary. We assist with pre-authorization by providing the requisition form and clinical notes. Contact our billing team at +971 54 548 8731 for a free benefits check.

UAE Regulatory & Data Privacy Adherence

This test adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. All samples are processed under an ISO 9001:2015 quality management system at DNA Labs UAE, DHA Facility License 1143. Genetic counselling is provided pre- and post-test in compliance with DHA guidelines.

Clinical & Logistical Metadata

Test Name	VPS35 Gene (PARK17) Parkinson's Disease Genetic Test
Price (AED)	2800
Turnaround Time	3 to 4 Weeks
Sample Type / Matrix	Whole Blood, Extracted DNA, or One Drop Blood on FTA Card
Methodology Used	Next Generation Sequencing (NGS) – full gene analysis
ICD-10-CM Code	G20
LOINC Code	93852-2
DHA Facility License & Laboratory Address Invariants	DHA License No: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE